Skip to main content
SpringerLink
Log in

Eine sinnvolle Therapieergänzung bei persistierender Negativsymptomatik?

5-HT3-Rezeptorantagonisten bei Schizophrenie

  • journal club
  • Published:
InFo Neurologie & Psychiatrie Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  • Kishi T, Mukai T, Matsuda Y et al. Selective serotonin-3 receptor antagonist treatment for schizophrenia: Meta-analysis and systematic review. Neuromolecular Med 2014; 16: 61–69

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Psychiatrische und Psychotherapeutische Klinik, Universitätsklinikum Erlangen, Deutschland

    Ozan Yüksel Tektaş

Authors
  1. Ozan Yüksel Tektaş
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ozan Yüksel Tektaş.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Tektaş, O.Y. Eine sinnvolle Therapieergänzung bei persistierender Negativsymptomatik?. InFo Neurologie 16, 31 (2014). https://doi.org/10.1007/s15005-014-0760-3

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s15005-014-0760-3

Search

Navigation